Author

T. Ackermann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

C. F. Calkhoven· 2 shared G. Kortman· 2 shared M. A. Zaini· 2 shared A. de Bruin· 1 shared B. A. Sterken· 1 shared C. Müller· 1 shared C. Nixon· 1 shared D. S. Verbeek· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. F. Calkhoven

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Breast cancer secretes anti-ferroptotic MUFAs and depends on selenoprotein synthesis for metastasis

T. Ackermann, E. Shokry, R. Deshmukh, J. Anand, L. C. A. Galbraith, L. Mitchell, G. Rodriguez-Blanco, V. H. Villar, B. A. Sterken, C. Nixon, S. Zanivan, K. Blyth, D. Sumpton, S. Tardito

This study shows that triple-negative breast cancer cells secrete anti-ferroptotic MUFAs and rely on selenoprotein synthesis for metastasis.

bioRxiv · Jun 13, 2023Cancer Biology

C/EBPβ-LIP dually activates glycolysis and the malate aspartate shuttle to maintain NADH/NAD+ homeostasis

T. Ackermann, H. R. Zuidhof, G. Kortman, M. G. S. Rutten, M. J. C. Broekhuis, M. A. Zaini, G. Hartleben, C. F. Calkhoven

This study shows that C/EBPβ-LIP activates both glycolysis and the malate-aspartate shuttle to maintain NADH/NAD+ homeostasis, and inhibiting both could be a strategy for cancer treatment.

bioRxiv · Oct 9, 2020 · PreprintCancer Biology

Reduced expression of C/EBPβ-LIP extends health- and lifespan in mice

C. Müller, L. M. Zidek, T. Ackermann, T. de Jong, P. Liu, V. Kliche, M. A. Zaini, G. Kortman, L. Harkema, D. S. Verbeek, J. P. Tuckermann, J. von Maltzahn, A. de Bruin, Z.-Q. Wang, V. Guryev, C. F. Calkhoven

This study shows that reducing C/EBPβ-LIP expression in mice delays age-related phenotypes and extends lifespan, suggesting therapeutic potential for age-related diseases.

bioRxiv · Jan 18, 2018Cell Biology